Aptevo Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference
November 23 2016 - 9:03AM
Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company
focused on developing novel oncology and hematology therapeutics,
today announced that it will present at the 28th Annual Piper
Jaffray Healthcare Conference on Wednesday, November 30, 2016 at
1:00 pm EST at the Lotte New York Palace Hotel.
A live audio webcast of the presentation can be
accessed at www.aptevotherapeutics.com under the ‘Investors’
section of the website, under ‘Events.’ An audio reply of the
webcast will be available following the live webcast.
About Aptevo Therapeutics
Inc.
Aptevo Therapeutics Inc. is a biotechnology
company focused on novel oncology and hematology therapeutics to
meaningfully improve patients’ lives. Our core technology is the
ADAPTIR™ (modular protein technology) platform. Aptevo has four
commercial products in the areas of hematology and infectious
diseases, as well as various investigational stage product
candidates in immuno-oncology.
Source:Aptevo Therapeutics
Stacey JurchisonSenior Director, Investor Relations and Corporate
Communications206-859-6628 JurchisonS@apvo.com
Aptevo Therapeutics (NASDAQ:APVO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Aptevo Therapeutics (NASDAQ:APVO)
Historical Stock Chart
From Oct 2023 to Oct 2024